Conform Pharm Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 5

Conform Pharm General Information

Description

Developer of high-end complex generic drugs designed to treat a variety of diseases. The company's drugs leverage nano-preparation technology to create a number of generic drugs and improved new drugs under research in the oral, transdermal, injection and injection slow-controlled release applications of insoluble drugs, which mainly focuses on the fields of infantile hemangioma, vascular skin diseases, percutaneous superficial analgesia, and injection sustained and controlled release analgesia, enabling the healthcare industry to better treat diseases across varying types and seriousness.

Contact Information

Website
www.whkfxy.com
Formerly Known As
Beijing Maifuweier Pharmaceutical Technology Co., Ltd., Wuhan Maifuweier Pharmaceutical Technology Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • C016, Building B4, Building B4-B8, Wuhan National Bioindustry Base
  • No. 666 Gaoxin Avenue, East Lake New Technology Development Zone
  • Wuhan, Hubei 430074
  • China
+86 027
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • C016, Building B4, Building B4-B8, Wuhan National Bioindustry Base
  • No. 666 Gaoxin Avenue, East Lake New Technology Development Zone
  • Wuhan, Hubei 430074
  • China
+86 027

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Conform Pharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Conform Pharm‘s full profile, request access.

Request a free trial

Conform Pharm Patents

Conform Pharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4026565-A1 Transdermal penetration enhancing composition and application thereof in timolol preparation Active 04-Sep-2019
EP-4026565-A4 Transdermal penetration enhancing composition and application thereof in timolol preparation Active 04-Sep-2019
EP-4026565-B1 Transdermal penetration enhancing composition and application thereof in timolol preparation Active 04-Sep-2019
EP-4026565-C0 Transdermal penetration enhancing composition and application thereof in timolol preparation Active 04-Sep-2019
GB-2600633-A Transdermal penetration enhancing composition and application thereof in timolol preparation Active 04-Sep-2019 A61K31/5377
To view Conform Pharm’s complete patent history, request access »

Conform Pharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Conform Pharm‘s full profile, request access.

Request a free trial

Conform Pharm FAQs

  • When was Conform Pharm founded?

    Conform Pharm was founded in 2007.

  • Where is Conform Pharm headquartered?

    Conform Pharm is headquartered in Wuhan, China.

  • What industry is Conform Pharm in?

    Conform Pharm’s primary industry is Pharmaceuticals.

  • Is Conform Pharm a private or public company?

    Conform Pharm is a Private company.

  • What is Conform Pharm’s current revenue?

    The current revenue for Conform Pharm is .

  • Who are Conform Pharm’s investors?

    Optics Valley Financial Holdings Group, THG Ventures, Billionhome, Sunz Fund, and Tibet Dorui Pharmaceutical are 5 of 11 investors who have invested in Conform Pharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process